Zhihai Peng

2.4k total citations
33 papers, 1.8k citations indexed

About

Zhihai Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhihai Peng has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Zhihai Peng's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Zhihai Peng is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Zhihai Peng collaborates with scholars based in China, United States and Sweden. Zhihai Peng's co-authors include Huamei Tang, Dongwang Yan, Chongzhi Zhou, Zhongbo Han, Guoqiang Qiu, Junyi Wu, Hong‐Yuan Chen, Junwei Fan, Jun Xia and Xiaoliang Wang and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and FEBS Letters.

In The Last Decade

Zhihai Peng

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihai Peng China 23 1.3k 937 325 220 186 33 1.8k
Yulong Shang China 22 1.2k 1.0× 761 0.8× 309 1.0× 182 0.8× 177 1.0× 55 1.8k
Shu Shimada Japan 22 1.0k 0.8× 604 0.6× 354 1.1× 203 0.9× 124 0.7× 43 1.4k
Dongwang Yan China 27 1.8k 1.4× 1.3k 1.3× 458 1.4× 205 0.9× 155 0.8× 48 2.3k
Mélanie Letexier France 12 1.3k 1.0× 432 0.5× 304 0.9× 156 0.7× 111 0.6× 17 2.0k
Hong Zheng China 21 1.1k 0.9× 1.0k 1.1× 240 0.7× 159 0.7× 73 0.4× 40 1.6k
Vincent W. Keng Hong Kong 27 1.4k 1.1× 268 0.3× 195 0.6× 204 0.9× 222 1.2× 60 2.0k
Huahong Xie China 22 812 0.6× 441 0.5× 249 0.8× 120 0.5× 83 0.4× 43 1.1k
Hisaki Igarashi Japan 25 945 0.8× 289 0.3× 389 1.2× 322 1.5× 217 1.2× 52 1.5k
Raffaella Zamponi Italy 17 1.8k 1.4× 339 0.4× 665 2.0× 189 0.9× 128 0.7× 26 2.2k

Countries citing papers authored by Zhihai Peng

Since Specialization
Citations

This map shows the geographic impact of Zhihai Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihai Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihai Peng more than expected).

Fields of papers citing papers by Zhihai Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihai Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihai Peng. The network helps show where Zhihai Peng may publish in the future.

Co-authorship network of co-authors of Zhihai Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihai Peng. A scholar is included among the top collaborators of Zhihai Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihai Peng. Zhihai Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Changcan, Xisheng Liu, Yuan Liu, et al.. (2018). Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway. Cell Death and Disease. 9(10). 1009–1009. 46 indexed citations
2.
3.
Zhao, Senlin, Hongcheng Sun, Weiliang Jiang, et al.. (2017). miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Molecular Cancer. 16(1). 12–12. 66 indexed citations
4.
Jiang, Tao, Ling Ye, Zhongbo Han, et al.. (2017). miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses. Journal of Experimental & Clinical Cancer Research. 36(1). 131–131. 76 indexed citations
5.
Han, Yang, Su Lu, Fudong Yu, et al.. (2016). A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers. Scientific Reports. 6(1). 37240–37240. 3 indexed citations
6.
Ye, Ling, Shengtao Lin, Yushuai Mi, et al.. (2016). Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target. Tumor Biology. 37(11). 14585–14594. 36 indexed citations
7.
Chen, Dawei, Sheng Chen, Zhaowen Wang, et al.. (2016). Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation. International Journal of Clinical Oncology. 21(6). 1111–1119. 6 indexed citations
8.
Fang, Chao, Chuanwen Fan, Cun Wang, et al.. (2016). CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer. Oncotarget. 7(47). 77389–77403. 37 indexed citations
9.
Wang, Yang, Yanfei Cao, Tao Yu, et al.. (2016). Allele-specific expression of mutated in colorectal cancer (MCC) gene and alternative susceptibility to colorectal cancer in schizophrenia. Scientific Reports. 6(1). 26688–26688. 11 indexed citations
10.
Song, Guohe, Shifeng Xu, Hong Zhang, et al.. (2016). TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway. Journal of Experimental & Clinical Cancer Research. 35(1). 148–148. 214 indexed citations
11.
Sun, Hongcheng, Huamei Tang, Dacheng Xie, et al.. (2015). Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6. Clinical Cancer Research. 22(2). 502–512. 28 indexed citations
12.
Wang, Jingtao, Feifei Cui, Xiao Wang, et al.. (2015). Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer. Journal of Experimental & Clinical Cancer Research. 34(1). 13–13. 32 indexed citations
13.
Zhang, Jinyan, Tao Huang, Fan Zhang, et al.. (2015). Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma. Tumor Biology. 36(4). 2257–2261. 9 indexed citations
14.
Jiang, Tao, Huamei Tang, Zehua Wu, et al.. (2013). Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Medical Oncology. 30(2). 534–534. 45 indexed citations
15.
Han, Zhongbo, Lin Zhong, Mujian Teng, et al.. (2012). Identification of recurrence‐related microRNAs in hepatocellular carcinoma following liver transplantation. Molecular Oncology. 6(4). 445–457. 102 indexed citations
16.
Chen, Hong‐Yuan, Zhongbo Han, Junwei Fan, et al.. (2011). miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver. Medical Oncology. 29(3). 1859–1865. 49 indexed citations
17.
Wang, Quan, Yugang Wen, Dapeng Li, et al.. (2010). Upregulated INHBA expression is associated with poor survival in gastric cancer. Medical Oncology. 29(1). 77–83. 188 indexed citations
18.
Fan, Jia, Guang-Shun Yang, Zhiren Fu, et al.. (2009). Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. Journal of Cancer Research and Clinical Oncology. 135(10). 1403–1412. 87 indexed citations
19.
Li, Dawei, Dongwang Yan, Huamei Tang, et al.. (2009). IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis. Annals of Surgical Oncology. 16(12). 3499–3506. 94 indexed citations
20.
Wang, Liwei, Xiaohong Guan, Weida Gong, et al.. (2005). Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer. Clinical & Experimental Metastasis. 22(3). 205–213. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulong Shang Breakdown of academic impact, for papers by Shu Shimada Breakdown of academic impact, for papers by Dongwang Yan Breakdown of academic impact, for papers by Mélanie Letexier Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Vincent W. Keng Breakdown of academic impact, for papers by Huahong Xie Breakdown of academic impact, for papers by Hisaki Igarashi Breakdown of academic impact, for papers by Raffaella Zamponi
Rankless by CCL
2026